Supplements
Should I Worry About My IGF-1 Result?
An out-of-range IGF-1 result catches a lot of people off guard — it rarely appears on standard panels, so when it shows up flagged, the questions pile up fast. IGF-1 sits at the center of growth, metabolism, and longevity signaling, and both too-high and too-low values carry distinct health implications worth understanding.

Should I Worry About My IGF-1 Result?
For most adults, a single IGF-1 result outside the reference range is worth monitoring but not panicking about — context matters enormously. High IGF-1 is concerning if it reflects pituitary overactivity (acromegaly) or consistently excessive growth hormone drive; low IGF-1 is a signal of undernutrition, poor sleep, or age-related decline. The exception: values more than 2 standard deviations outside age-adjusted norms warrant a conversation with an endocrinologist, not a supplement.
---
What IGF-1 Actually Is — and Why Labs Test It
Insulin-like Growth Factor 1 (IGF-1) is a peptide hormone produced primarily in the liver in response to growth hormone (GH) signaling. Unlike GH itself — which pulses throughout the day — IGF-1 circulates at relatively stable levels, making it a far more practical clinical proxy for overall GH activity. That stability is exactly why endocrinologists prefer it for monitoring conditions like acromegaly, GH deficiency, and growth disorders.
Beyond the pituitary axis, IGF-1 plays a broad role in anabolic metabolism: it drives protein synthesis in muscle, stimulates bone mineralization, supports neuronal survival, and modulates insulin sensitivity. The signaling pathway it activates — the IGF-1R/PI3K/Akt axis — is one of the most studied in longevity biology, partly because organisms with reduced IGF-1 signaling (from C. elegans to mice) consistently show extended lifespan (Kenyon et al., Nature 1993; PMID: 8247153).
That evolutionary paradox — IGF-1 is anabolic and vital for growth, yet lower levels correlate with longer life in model organisms — is precisely why interpreting your result requires nuance.
---
Understanding Your IGF-1 Reference Range
Reference ranges are strongly age-dependent. Peak IGF-1 occurs during puberty (often 400–700 ng/mL in adolescents) and declines progressively through adulthood. The table below gives approximate adult reference ranges from laboratory medicine consensus:
| Age Range | Typical IGF-1 Reference Range (ng/mL) |
|---|---|
| 18–24 | 115–355 |
| 25–39 | 100–303 |
| 40–54 | 71–263 |
| 55–69 | 58–220 |
| 70+ | 35–175 |
Note: Exact ranges vary by laboratory assay and sex. Always interpret against your lab's own reference interval.
Sex matters too: premenopausal women tend to run slightly higher than age-matched men, and oral estrogen (but not transdermal) can suppress hepatic IGF-1 production, artificially lowering the result (Ho et al., Journal of Clinical Endocrinology & Metabolism 2006; PMID: 16595597).
If you're on oral hormone therapy, your IGF-1 result may underrepresent true GH secretion — a nuance worth flagging with your provider.
---
What Does a High IGF-1 Result Mean?
Elevated IGF-1 — particularly a result more than 2 standard deviations above the age-adjusted mean — raises several considerations:
1. Pituitary adenoma / acromegaly. This is the first thing endocrinologists rule out. A GH-secreting pituitary tumor drives persistently elevated IGF-1 and produces the classic features of acromegaly (jaw enlargement, hand/foot growth, coarsened facial features). If you have any of these symptoms alongside a high result, imaging is warranted — not supplements.
2. Exogenous GH or peptide use. Recombinant GH, GH secretagogues (ipamorelin, sermorelin, MK-677), or certain anabolic compounds artificially elevate IGF-1. Labs increasingly test for this in athlete panels.
3. Dietary and lifestyle drivers. In people without pituitary pathology, chronically elevated IGF-1 is associated with high dairy intake, caloric surplus, and elevated insulin — all of which upregulate hepatic IGF-1 output. A landmark analysis of the EPIC cohort found that higher milk consumption was independently associated with elevated circulating IGF-1 (Crowe et al., European Journal of Clinical Nutrition 2009; PMID: 18728703).
4. Cancer risk signal. Sustained high IGF-1 has been associated in observational studies with modestly increased risk for colorectal, prostate, and breast cancer — likely because IGF-1R signaling promotes cell proliferation and inhibits apoptosis. A meta-analysis found a relative risk of approximately 1.49 for prostate cancer in men in the highest IGF-1 quartile versus the lowest (Renehan et al., Lancet 2004; PMID: 15016485). This is a population-level association, not an individual diagnosis — but it's a reason not to chase high IGF-1 through GH secretagogues recreationally.
---
What Does a Low IGF-1 Result Mean?
Low IGF-1 is at least as clinically meaningful as high IGF-1 and is more common in general adult populations. Key causes:
- Protein undernutrition. IGF-1 is exquisitely sensitive to dietary protein intake. Even short periods of caloric restriction or low protein can suppress it significantly. This is why IGF-1 is used as a nutritional status biomarker in clinical settings.
- Poor or insufficient sleep. The majority of pulsatile GH secretion occurs during slow-wave sleep. Chronic short sleep reduces GH pulses, which secondarily lowers IGF-1. If you want to know how often IGF-1 should be tested and whether your result reflects a true trend or a temporary dip, timing and lifestyle context matter.
- Hypothyroidism. Thyroid hormones potentiate GH signaling at the liver. Low free T3 or T4 blunts hepatic IGF-1 production independent of GH output — another reason to interpret IGF-1 alongside a full thyroid panel.
- Liver dysfunction. The liver is the primary site of IGF-1 synthesis. Hepatic disease, steatosis, or significant enzyme elevation can suppress output. Reviewing your ALT result alongside IGF-1 gives you a more complete picture of hepatic function.
- Age-related somatopause. The gradual decline of GH secretion with age — sometimes called somatopause — is a normal physiological process. By age 60, many adults have IGF-1 in the lower third of their younger reference range. Whether to intervene is controversial (see below).
Low IGF-1 is associated with reduced muscle mass, slower recovery from exercise, impaired bone density, cognitive decline risk, and increased all-cause mortality in some — but not all — epidemiological datasets. A large prospective study in older adults found a U-shaped mortality curve, with both very low and very high IGF-1 associated with higher risk (Rosen et al., Journal of Clinical Endocrinology & Metabolism 2012; PMID: 22442256).
---
The Longevity Paradox: Is Lower IGF-1 Better?
This is where the science gets genuinely complex. Animal data strongly favors lower IGF-1 for longevity. In humans, the picture is less clear-cut:
- Centenarians in some studies have lower IGF-1 signaling or IGF-1 receptor sensitivity, suggesting the pathway may need to be downregulated for extreme longevity (Suh et al., PNAS 2008; PMID: 18316725).
- Yet sarcopenic older adults with very low IGF-1 have worse functional outcomes and higher frailty scores.
- Caloric restriction — the most robust longevity intervention in animals — lowers IGF-1 in humans, but combining restriction with adequate protein blunts that reduction.
The practical takeaway: optimizing IGF-1 toward the middle of the age-adjusted range — not chasing the top — appears to be the most defensible strategy based on current human data.
---
Lifestyle and Nutritional Levers That Move IGF-1
If your result is below range and your provider agrees intervention is appropriate, several evidence-informed strategies can support IGF-1 without pharmaceutical GH:
Dietary protein. Ensuring adequate protein (1.2–1.6 g/kg body weight for active adults) is the single most potent nutritional lever for IGF-1. Research confirms that protein restriction — even without overall caloric restriction — significantly suppresses IGF-1 within days (Levine et al., Cell Metabolism 2014; PMID: 24606898).
Resistance training. Acute and chronic resistance exercise increases GH pulse amplitude and, over time, supports IGF-1 in the mid-to-upper reference range. This effect is particularly important in adults over 50.
Sleep optimization. Prioritizing 7–9 hours with adequate slow-wave sleep is the most underrated GH support strategy available without a prescription.
Zinc adequacy. Zinc is required for GH receptor signaling and hepatic IGF-1 synthesis. Deficiency — common in older adults, athletes with heavy sweat loss, and plant-dominant eaters — can contribute to suppressed IGF-1. Repletion in deficient individuals has been shown to restore IGF-1 toward normal range.
Managing insulin resistance. Paradoxically, while insulin stimulates hepatic IGF-1 output, chronic hyperinsulinemia and insulin resistance can derange the GH/IGF-1 axis. Reviewing your fasting insulin result alongside IGF-1 helps clarify whether metabolic dysfunction is part of the picture.
---
IGF-1 and Related Cardiometabolic Markers
IGF-1 doesn't operate in isolation. It interacts with several cardiometabolic pathways that your lab panel may already be capturing:
- Triglycerides: Low IGF-1 is associated with impaired fatty acid metabolism and can contribute to elevated triglycerides. If you're concerned about your triglycerides result, consider whether suboptimal GH/IGF-1 axis function is a contributing factor.
- Inflammation (CRP): IGF-1 has complex anti-inflammatory properties at physiological levels; very low IGF-1 may permit higher baseline inflammation. Your CRP result provides relevant context.
- Thyroid function: As noted above, thyroid hormones are upstream regulators of GH sensitivity. A suppressed IGF-1 with concurrent thyroid antibody elevation points toward autoimmune thyroid disease as a root cause worth investigating.
---
What This Means for Your Formula
Ones doesn't stock GH secretagogues or IGF-1-stimulating peptides — and deliberately so, given the cancer risk signals associated with pharmacologically elevated IGF-1. What Ones does address are the upstream nutritional gaps most commonly underlying a low or suboptimal IGF-1 result:
Zinc (as zinc bisglycinate, 15–30 mg). Ones includes zinc dosed to clinical repletion ranges, addressing one of the most common micronutrient contributors to blunted GH/IGF-1 signaling. Studies in zinc-deficient populations demonstrate meaningful IGF-1 recovery with adequate repletion.
Thyroid Support (Ones System Blend). For users whose IGF-1 appears low in the context of suboptimal thyroid function, the Ones Thyroid Support blend addresses nutritional cofactors — including selenium and iodine — that underpin T3/T4 synthesis and downstream GH receptor sensitivity.
Ashwagandha (KSM-66, 600 mg). Ashwagandha's effects on cortisol are relevant here: chronically elevated cortisol suppresses GH pulsatility. By reducing the HPA axis overactivation that blunts nocturnal GH release, KSM-66 at 600 mg supports the hormonal environment in which IGF-1 can recover toward optimal. This is a supporting role — not a direct IGF-1 stimulant — but it addresses a mechanism frequently overlooked in lab interpretation.
When users upload their lab results to Ones, the AI practitioner considers IGF-1 in the context of thyroid markers, fasting insulin, CRP, and lifestyle data before assembling a formula — because an isolated number rarely tells the full story.
---
Key Takeaways
- IGF-1 is best interpreted age-adjusted. A result that looks low for a 30-year-old may be normal for a 60-year-old; always use your lab's age-stratified reference range.
- High IGF-1 (>2 SD above mean) requires medical evaluation to rule out pituitary pathology before any lifestyle or supplement intervention.
- Low IGF-1 is most commonly driven by inadequate protein, poor sleep, zinc deficiency, hypothyroidism, or liver dysfunction — all addressable without pharmaceutical GH.
- The longevity evidence favors mid-range IGF-1, not the top of the range; chasing high IGF-1 through secretagogues carries real cancer-association risk.
- Zinc, thyroid support, and cortisol management are the most evidence-grounded nutritional levers for supporting a suboptimal IGF-1 result.
- Context is everything: IGF-1 read alongside fasting insulin, CRP, thyroid antibodies, and ALT gives a far clearer clinical picture than the number alone.